Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 20FR12B Initial registration of securities (foreign private issuers)
- 1.1 Exhibit 1.1
- 1.2 Exhibit 1.2
- 1.3 Exhibit 1.3
- 1.4 Exhibit 1.4
- 1.5 Exhibit 1.5
- 1.6 Exhibit 1.6
- 1.7 Exhibit 1.7
- 2.1 Exhibit 2.1
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 4.7 Exhibit 4.7
- 4.8 Exhibit 4.8
- 4.9 Exhibit 4.9
- 4.10 Exhibit 4.10
- 15.1 Exhibit 15.1
- 15.2 Exhibit 15.2
TRIL similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our reports dated March 27, 2014 and April 29, 2013 with respect to the financial statements of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) in the Registration Statement on Form 20-F for the registration of common shares of Trillium Therapeutics Inc.
/s/ Ernst & Young LLP | |
Toronto, Canada | Chartered Accountants |
August 12, 2014 | Licensed Public Accountants |